SPECT Business Sale: Recent chatter on social media has centered around Lantheus Holdings' completion of the sale of its SPECT business to SHINE Technologies. Many users are discussing how this divestiture could streamline the company’s focus on radiopharmaceuticals. The move is seen as a strategic pivot, sparking varied opinions on its long-term impact.
Stock Performance Buzz: Conversations also touch on the stock’s potential, with some on social media suggesting it might be undervalued given the company’s niche in medical imaging. Others are cautious, pointing to broader market uncertainties affecting biotech stocks. The mix of optimism and skepticism keeps the discussion lively and dynamic.
Note: This discussion summary was generated from an AI condensation of post data.
Lantheus Holdings Insider Trading Activity
Lantheus Holdings insiders have traded $LNTH stock on the open market 5 times in the past 6 months. Of those trades, 0 have been purchases and 5 have been sales.
Here’s a breakdown of recent trading of $LNTH stock by insiders over the last 6 months:
- PARTNERS L L C/CA FARALLON has made 0 purchases and 2 sales selling 3,406,000 shares for an estimated $191,213,690.
- RAJIV A PATEL has made 0 purchases and 2 sales selling 3,406,000 shares for an estimated $191,213,690.
- PAUL BLANCHFIELD (President) sold 3,060 shares for an estimated $163,924
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
Lantheus Holdings Revenue
Lantheus Holdings had revenues of $384M in Q3 2025. This is an increase of 1.39% from the same period in the prior year.
You can track LNTH financials on Quiver Quantitative's LNTH stock page.
Lantheus Holdings Hedge Fund Activity
We have seen 178 institutional investors add shares of Lantheus Holdings stock to their portfolio, and 306 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- FARALLON CAPITAL MANAGEMENT LLC removed 3,245,000 shares (-48.3%) from their portfolio in Q3 2025, for an estimated $166,436,050
- MORGAN STANLEY added 3,137,343 shares (+423.5%) to their portfolio in Q3 2025, for an estimated $160,914,322
- WESTFIELD CAPITAL MANAGEMENT CO LP removed 1,495,072 shares (-100.0%) from their portfolio in Q3 2025, for an estimated $76,682,242
- T. ROWE PRICE INVESTMENT MANAGEMENT, INC. removed 1,426,298 shares (-100.0%) from their portfolio in Q3 2025, for an estimated $73,154,824
- ASSENAGON ASSET MANAGEMENT S.A. added 1,280,054 shares (+inf%) to their portfolio in Q3 2025, for an estimated $65,653,969
- INVESCO LTD. removed 950,761 shares (-56.5%) from their portfolio in Q3 2025, for an estimated $48,764,531
- WELLINGTON MANAGEMENT GROUP LLP removed 947,367 shares (-55.1%) from their portfolio in Q3 2025, for an estimated $48,590,453
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
Lantheus Holdings Government Contracts
We have seen $37,827,531 of award payments to $LNTH over the last year.
Here are some of the awards which we have have seen pay out the most over the last year:
- FLUORINE 18 PIFLUFOLASTAT - PYLARIFY: $2,490,016
- PYLARIFY - CLEVELAND VAMC: $1,972,708
- 480 F18 PYLARIFY DOSES POP 1/1/2025 - 12/31/2025: $1,734,185
- DELIVERY ORDER FOR PYLARIFY: $1,571,749
- F 18 PYLARIFY RADIOPHARMACEUTICAL. BASE IDIQ CONTRACT.: $1,497,618
To track government contracts to publicy traded companies, check out Quiver Quantitative's government contracts dashboard.
Lantheus Holdings Analyst Ratings
Wall Street analysts have issued reports on $LNTH in the last several months. We have seen 5 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Truist Securities issued a "Buy" rating on 12/18/2025
- Mizuho issued a "Outperform" rating on 12/17/2025
- B. Riley Securities issued a "Buy" rating on 09/16/2025
- TD Cowen issued a "Buy" rating on 09/15/2025
- JMP Securities issued a "Market Outperform" rating on 08/07/2025
To track analyst ratings and price targets for Lantheus Holdings, check out Quiver Quantitative's $LNTH forecast page.
Lantheus Holdings Price Targets
Multiple analysts have issued price targets for $LNTH recently. We have seen 6 analysts offer price targets for $LNTH in the last 6 months, with a median target of $78.5.
Here are some recent targets:
- Richard Newitter from Truist Securities set a target price of $82.0 on 12/18/2025
- Anthony Petrone from Mizuho set a target price of $72.0 on 12/17/2025
- Paul Choi from Goldman Sachs set a target price of $77.0 on 10/08/2025
- Justin Walsh from B. Riley Securities set a target price of $84.0 on 09/16/2025
- Tara Bancroft from TD Cowen set a target price of $80.0 on 09/15/2025
- David Turkaly from JMP Securities set a target price of $73.0 on 08/07/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
